Pages that link to "Q24201246"
Jump to navigation
Jump to search
The following pages link to Caffeine as an analgesic adjuvant for acute pain in adults (Q24201246):
Displaying 15 items.
- Caffeine as an analgesic adjuvant for acute pain in adults (Q24187350) (← links)
- Non-prescription (OTC) oral analgesics for acute pain - an overview of Cochrane reviews (Q24188036) (← links)
- Non-prescription (OTC) oral analgesics for acute pain- an overview of Cochrane reviews (Q24197937) (← links)
- Antibiotic Resistance: What are the Opportunities for Primary Care in Alleviating the Crisis? (Q26823561) (← links)
- The Role of Caffeine in Pain Management: A Brief Literature Review (Q28069184) (← links)
- The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance (Q28303831) (← links)
- Expression and characterization of purinergic receptors in rat middle meningeal artery-potential role in migraine (Q35284591) (← links)
- Dexketoprofen/tramadol: randomised double-blind trial and confirmation of empirical theory of combination analgesics in acute pain (Q35798596) (← links)
- A Preliminary Study on the Effects of Self-Reported Dietary Caffeine on Pain Experience and Postoperative Analgesia (Q36752651) (← links)
- Caffeine as an opioid analgesic adjuvant in fibromyalgia (Q38621333) (← links)
- Pain transduction: a pharmacologic perspective (Q38823502) (← links)
- Effects of upper respiratory tract illnesses, ibuprofen and caffeine on reaction time and alertness (Q44740732) (← links)
- Gastro-protective effect of methanol extract of Vernonia amygdalina (del.) leaf on aspirin-induced gastric ulcer in Wistar rats. (Q55021584) (← links)
- Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed-Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU as Acid or Lysinate Under Fasted and Fed Conditions-Data From 2 Single-Center, Single-Dose, Randomized Crossove (Q64112950) (← links)
- Caffeine and Primary (Migraine) Headaches-Friend or Foe? (Q92071235) (← links)